LT4114404T - Skausmo, susijusio su diabetine periferine neuropatija, gydymas - Google Patents

Skausmo, susijusio su diabetine periferine neuropatija, gydymas

Info

Publication number
LT4114404T
LT4114404T LTEPPCT/US2022/072497T LTUS2022072497T LT4114404T LT 4114404 T LT4114404 T LT 4114404T LT US2022072497 T LTUS2022072497 T LT US2022072497T LT 4114404 T LT4114404 T LT 4114404T
Authority
LT
Lithuania
Prior art keywords
pain associated
peripheral neuropathy
treating pain
diabetic peripheral
diabetic
Prior art date
Application number
LTEPPCT/US2022/072497T
Other languages
English (en)
Inventor
Basil. RIGAS
Original Assignee
Medicon Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicon Pharmaceuticals, Inc. filed Critical Medicon Pharmaceuticals, Inc.
Publication of LT4114404T publication Critical patent/LT4114404T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/US2022/072497T 2021-05-24 2022-05-23 Skausmo, susijusio su diabetine periferine neuropatija, gydymas LT4114404T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163192248P 2021-05-24 2021-05-24
PCT/US2022/072497 WO2022251806A1 (en) 2021-05-24 2022-05-23 Treating pain associated with diabetic peripheral neuropathy

Publications (1)

Publication Number Publication Date
LT4114404T true LT4114404T (lt) 2023-11-10

Family

ID=82115530

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2022/072497T LT4114404T (lt) 2021-05-24 2022-05-23 Skausmo, susijusio su diabetine periferine neuropatija, gydymas

Country Status (22)

Country Link
US (1) US20240100073A1 (lt)
EP (2) EP4114404B1 (lt)
JP (1) JP2024520465A (lt)
KR (1) KR20240012356A (lt)
CN (1) CN117377475A (lt)
AU (1) AU2022280139A1 (lt)
BR (1) BR112023024426A2 (lt)
CA (1) CA3220196A1 (lt)
DK (1) DK4114404T3 (lt)
ES (1) ES2961829T3 (lt)
FI (1) FI4114404T3 (lt)
HR (1) HRP20230842T1 (lt)
HU (1) HUE062996T2 (lt)
LT (1) LT4114404T (lt)
MA (1) MA58890B1 (lt)
MD (1) MD4114404T2 (lt)
MX (1) MX2023013853A (lt)
PL (1) PL4114404T3 (lt)
PT (1) PT4114404T (lt)
RS (1) RS64402B1 (lt)
SI (1) SI4114404T1 (lt)
WO (1) WO2022251806A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024112725A1 (en) 2022-11-23 2024-05-30 Medicon Pharmaceuticals, Inc. Treating pain associated with central sensitization

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2705463C (en) 2007-08-10 2014-10-07 Basil Rigas Anti-inflammatory compounds and uses thereof
WO2013067591A1 (en) * 2011-11-10 2013-05-16 Relevare Australia Pty Ltd Topical formulations for pain management
WO2013130625A1 (en) * 2012-02-27 2013-09-06 Basil Rigas Phospho-ester derivatives and uses thereof
US20140315834A1 (en) * 2012-09-21 2014-10-23 Medicon Pharmaceuticals, Inc. Compounds and compositions for use in the prevention and treatment of inflammation-related disorders, pain and fever, skin disorders, cancer and precancerous conditions thereof
US11510931B2 (en) * 2016-09-28 2022-11-29 Medicon Pharmaceuticals, Inc. Compositions and methods for treating ophthalmic conditions
WO2019067919A1 (en) 2017-09-28 2019-04-04 Medicon Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS
CN112955145A (zh) * 2018-09-04 2021-06-11 密涅瓦神经科学有限公司 使用苯氧丙胺化合物治疗疼痛的方法

Also Published As

Publication number Publication date
DK4114404T3 (da) 2023-09-18
KR20240012356A (ko) 2024-01-29
RS64402B1 (sr) 2023-08-31
MA58890B1 (fr) 2023-08-31
BR112023024426A2 (pt) 2024-02-20
WO2022251806A1 (en) 2022-12-01
FI4114404T3 (fi) 2023-09-05
JP2024520465A (ja) 2024-05-24
MX2023013853A (es) 2023-12-08
EP4114404A1 (en) 2023-01-11
PL4114404T3 (pl) 2024-01-03
HUE062996T2 (hu) 2023-12-28
ES2961829T3 (es) 2024-03-14
US20240100073A1 (en) 2024-03-28
PT4114404T (pt) 2023-10-19
AU2022280139A1 (en) 2024-01-18
CN117377475A (zh) 2024-01-09
EP4272826A3 (en) 2024-01-17
MD4114404T2 (ro) 2024-01-31
EP4114404B1 (en) 2023-07-19
SI4114404T1 (sl) 2023-12-29
CA3220196A1 (en) 2022-12-01
EP4272826A2 (en) 2023-11-08
HRP20230842T1 (hr) 2023-11-10

Similar Documents

Publication Publication Date Title
AR093386A1 (es) Composicion para tratar la diabetes o la diabesidad que comprende un analogo de oxintomodulina y metodo de tratamiento
LT4114404T (lt) Skausmo, susijusio su diabetine periferine neuropatija, gydymas
EP3793617A4 (en) TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY
EP3768889A4 (en) SUSTAINABLE ANTIMICROBIAL TREATMENT OF TEXTILES INTENDED FOR USE IN A HEALTH CARE ENVIRONMENT
EP4203962A4 (en) TREATMENT OF CANCER WITH A TLR AGONIST
SG11202103972SA (en) Neurological disease treatment with zilucoplan
PT4114403T (pt) Tratamento da dor neuropática associada à neuropatia periférica induzida por quimioterapia
PT3574912T (pt) Composição para tratamento de doença diabética
GB202116743D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GEP20237524B (en) Pharmaceutical combination comprising trazodone for the treatment of neuropathic pain
IL290403A (en) Prevention and treatment of hypoglycemia
GB202104609D0 (en) New Treatments for Pain
IL288776A (en) A needle composition, a skin stimulator containing it, and a manufacturing method thereof
GB202114373D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202102410D0 (en) Treatment